Emcure Pharma receives 7 US FDA observations for Sanand formulations facility in Gujarat

On Friday (May 15), shares of Emcure Pharmaceuticals Ltd ended at ₹1,702.30, up by ₹28.90, or 1.73%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *